PLK1 and cancer: In this study, to explore the potential of combining PLK1 inhibitors with immunotherapy in treating cancers, we analyzed the associations of PLK1 expression with immune cell infiltration and immune activities in 33 different cancer types based on the Cancer Genome Atlas (TCGA) data (https://cancergenome.nih.gov/).